PCELL.ST(PCELL.ST)
PCELL.ST
No analyst ratings available
No analyst price targets available for PCELL.ST
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $317M | $456M | $622M | $1.07B |
| Low | $317M | $456M | $602M | $1.07B |
| High | $317M | $456M | $643M | $1.07B |
| EBITDA Avg | $29M | $41M | $56M | $97M |
| Low | $29M | $41M | $54M | $97M |
| High | $29M | $41M | $58M | $97M |
| EBIT Avg | $15M | $22M | $30M | $52M |
| Low | $15M | $22M | $29M | $52M |
| High | $15M | $22M | $31M | $52M |
| Net Income Avg | $-72M | $-22M | $20M | — |
| Low | $-72M | $-22M | $20M | — |
| High | $-72M | $-22M | $20M | — |
| EPS Avg | $-1.24 | $-0.38 | $0.35 | — |
| Low | $-1.24 | $-0.38 | $0.35 | — |
| High | $-1.24 | $-0.38 | $0.35 | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / — |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $84M | $141M | $74M | $76M |
| Low | $84M | $141M | $74M | $76M |
| High | $84M | $141M | $74M | $76M |
| EBITDA Avg | $8M | $13M | $7M | $7M |
| Low | $8M | $13M | $7M | $7M |
| High | $8M | $13M | $7M | $7M |
| EBIT Avg | $4M | $7M | $4M | $4M |
| Low | $4M | $7M | $4M | $4M |
| High | $4M | $7M | $4M | $4M |
| Net Income Avg | $-12M | $6M | $-17M | $-17M |
| Low | $-12M | $6M | $-17M | $-17M |
| High | $-12M | $6M | $-17M | $-17M |
| EPS Avg | $-0.20 | $0.10 | $-0.30 | $-0.30 |
| Low | $-0.20 | $0.10 | $-0.30 | $-0.30 |
| High | $-0.20 | $0.10 | $-0.30 | $-0.30 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |